Top Markets
#1 Islamic Coin Islamic Coin +154.45%
#2 PulseChain PulseChain +48.38%
#3 Ergo Ergo +30.11%
#4 RedStone RedStone +16.56%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.64%
#6 SkyAI SkyAI +10.52%
#7 Siren Siren +8.99%
#8 Lighter Lighter +8.81%
#9 Monad Monad +8.67%
#10 OPENLOOT OPENLOOT +8.16%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Oncocross Co., Ltd. Oncocross Co., Ltd.

Oncocross Co., Ltd.

382150
Clasificación en acciones #27869
Oncocross Co., Ltd. undertakes collaborative research initiatives to discover... Oncocross Co., Ltd. undertakes collaborative research initiatives to discover new drugs, partnering with a variety of pharmaceutical companies both within South Korea and abroad. The company offers a fresh paradigm for drug development by providing analytical insights derived from its advanced artificial intelligence drug discovery platform. Founded by Yi-Rang Kim on June 22, 2015, Oncocross operates from its headquarters located in Seoul, South Korea.
Precio por acción
$2.50
Capitalización bursátil
$30.49M
Cambio (1 día)
7.11%
Cambio (1 año)
-59.56%
País
KR
Comercio Oncocross Co., Ltd. (382150)

Categoría

Healthcare
Ganancias de Oncocross Co., Ltd. (382150)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Oncocross Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Oncocross Co., Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH